Journal
CURRENT PHARMACEUTICAL DESIGN
Volume 21, Issue 32, Pages 4682-4687Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612821666150909094907
Keywords
Uveitis; treatment; pharmacotherapy; randomized clinical trial; outcome measures
Categories
Funding
- Fight for Sight (UK)
- Olivia's Vision (UK)
- MRC [G0600416] Funding Source: UKRI
- Fight for Sight [24NE142] Funding Source: researchfish
- Medical Research Council [G0600416] Funding Source: researchfish
- National Institute for Health Research [CL-2009-09-002] Funding Source: researchfish
Ask authors/readers for more resources
Uveitis is a term applied to a broad range of conditions characterized by intraocular inflammation. The pharmacological treatment of uveitis is controversial, with limited high-level evidence to inform most of the key treatment decisions that face the patient and clinician on a daily basis. In this review we identified twelve systematic reviews (including two Cochrane reviews) focused on key therapeutic questions in infectious and noninfectious uveitis. Our analysis of these reviews demonstrates the paucity of trial evidence available to inform these important clinical decisions. We consider the reasons for this, and look at the way forward for clinical trials in uveitis, so that we can move from controversy to clarity in the pharmacotherapy of uveitis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available